PhD Defence Gabriele Sassi

November 7, 2023
Congratulations to Gabriele Sassi, now better known as Dr. Sassi, for defending this PhD thesis entitled 'Multi-omics technologies to identify biomarkers for therapy prediction and response in type 1 diabetes.' We thank the jury members Alice Long (Benaroya Research Institute, Virginia Mason Medical Center, Seattle, USA), Jo Van Ginderachter (Vrije Universiteit Brussel (VUB), Brussels, Belgium), Ben Sprangers (Ziekenhuis Oost-Limburg (ZOL), Genk, Belgium), and Thierry Voet (KU Leuven, Leuven, Belgium) for the interesting discussions regarding his thesis subject.
Share this post

This PhD project aimed to use deep sequencing of single-cell RNAs to identify the unique gene expression profiles and heterogeneities in islet-derived white blood cells during autoimmune type 1 diabetes progression but also from therapeutic responders and non-responders. Moreover, he wanted to correlate these tissue-specific immune signatures with circulating (cell-free plasma) small non-coding RNAs during disease progression and in responders and non-responders pre- and post-therapy to identify potential markers for disease staging, prognosis, and therapy prediction.

The full text can be found via this link.

Support us

Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund. 

By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and curing type 1 diabetes.
Every contribution moves us one step closer to breakthroughs that matter.